论文部分内容阅读
目的探讨腹腔镜下保留脾脏胰体尾切除术治疗胰体尾部肿瘤的临床疗效,并评价其可行性和安全性。方法选取攀枝花市中心医院收治的16例胰体尾部肿瘤患者为研究对象,行腹腔镜下保留脾脏胰体尾切除术进行治疗,统计分析手术时间、手术出血量、住院时间及术后并发症等临床资料。结果 16例患者手术时间(240±48)min,手术出血量(425±210)ml,进食时间(5.5±1.2)d,住院时间(12.4±7.2)d。术后并发胰瘘2例,合并感染2例,肠梗阻3例,经保守性治疗后治愈;所有患者均未进行二次手术,术后无腹腔出血、胃肠穿孔、脾梗死等并发症。术后随访18~36个月,无肿瘤复发、转移及死亡病例。结论腹腔镜下保留脾脏胰体尾切除术用于治疗胰体尾部肿瘤临床疗效显著,住院时间短,并发症及不良反应少,值得推广应用。
Objective To investigate the clinical efficacy of laparoscopic splenic pancreatectomy for the treatment of pancreatic body tail tumors and to evaluate its feasibility and safety. Methods Twenty-six patients with pancreatic body and tail tumors treated in Panzhihua Central Hospital were enrolled in this study. Patients undergoing laparoscopic resection of splenic pancreatalectomy were selected for treatment. The operative time, operative bleeding, length of hospital stay and postoperative complications were analyzed statistically clinical information. Results The operation time (240 ± 48) min, operation bleeding time (425 ± 210) ml, food intake time (5.5 ± 1.2) days and hospital stay time (12.4 ± 7.2) days were all higher in 16 patients. Postoperative pancreatic fistula in 2 cases, 2 cases of combined infection, intestinal obstruction in 3 cases, after conservative treatment and cure; all patients did not perform the second surgery, no postoperative abdominal bleeding, gastrointestinal perforation, splenic infarction and other complications. All the patients were followed up for 18-36 months without tumor recurrence, metastasis and death. Conclusions The laparoscopic splenic pancreatic body resection for the treatment of pancreatic body tail tumor significant clinical efficacy, shorter hospital stay, fewer complications and adverse reactions, it is worth promoting the application.